Trial intelligence / Profile preview

Vitamin D in Allergic Bronchopulmonary Aspergillosis

NCT03133299Phase 3Completed

Sponsor
Post Graduate Institute of Medical Education and Research
Start
Dec 2016
Primary completion
Jun 2018
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 3 trial of vitamin d in allergic bronchopulmonary aspergillosis (ABPA), sponsored by Post Graduate Institute of Medical Education and Research. Started Dec 2016; status: completed.

02

Drugs

vitamin d
03

Conditions

allergic bronchopulmonary aspergillosis (ABPA)

Beyond the preview

Go deeper on NCT03133299.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03133299.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call